Clinical Trials Insight: 700023568
Phase of Trial: Phase II
Latest Information Update: 02 Jun 2011
At a glance
- Drugs BGC 201259 (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- Sponsors BTG
- 02 Apr 2009 Status changed from planning to discontinued, as reported in BTG media release.
- 19 May 2008 According to BTG media release trial scheduled to start in the second half of 2008.
- 13 Nov 2007 Endpoints added.